Names | |
---|---|
IUPAC name 3-carbamoylamino-2-methoxypropylmercury(II) chloride | |
Systematic IUPAC name 3-chloro-mercura-2-methoxy propylurea | |
Other names
| |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ECHA InfoCard | 100.000.483 |
PubChem CID | |
SMILES
| |
Properties | |
Chemical formula | C5H11ClHgN2O2 |
Molar mass | 367.20 g·mol |
Appearance | Solid |
Melting point | 152.5 °C (306.5 °F; 425.6 K) |
Solubility in water | 11 g/L |
Hazards | |
Occupational safety and health (OHS/OSH): | |
Main hazards | Renal mercury poisoning |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references |
Clinical data | |
---|---|
AHFS/Drugs.com | Medical Encyclopedia |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.000.483 |
Chemical and physical data | |
Formula | C5H11ClHgN2O2 |
Molar mass | 367.20 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Chlormerodrin is a mercurial diuretic commercially traded from 1952 until 1974 that was once used to treat patients with heart failure, but is no longer in widespread use. The radiolabelled form (Hg & Hg) had also been used for medical imaging of the kidney and brain and the Hg form was even considered a contender for Tc by some physicians, but was ultimately discontinued by the FDA in 1989.
References
- Sittig M (1988). Pharmaceutical Manufacturing Encyclopedia. Westwood: Noyes Publications.
- Crout JR (1974). "Fixed combination prescription drugs: FDA policy". Journal of Clinical Pharmacology. 14 (5–6): 249–254. doi:10.1002/j.1552-4604.1974.tb02309.x. PMID 4829517. S2CID 5830209.
- Leff WA, Nussbaum HE (April 1959). "Chlormerodrin: clinical effectiveness and absence of toxicity in congestive heart failure; report of a four-year study". British Medical Journal. 1 (5126): 883–889. doi:10.1136/bmj.1.5126.883. PMC 1992943. PMID 13629153.
- "Chlormerodrin". PubChem. U.S. National Library of Medicine. Retrieved 2021-09-23.
- Sodee DB, Di Stefano B (September 1965). "The Clinical Value of Today's Radioisotope Scanning". The Ohio State Medical Journal. 61: 819–22. PMID 14340215.
- Yamamoto YL, Feindel W, Zanelli J (September 1964). "Comparative study of radioactive chlormerodrin (Neohydrin) tagged with mercury 197 and mercury 203 for brain scanning". Neurology. 14 (9): 815–820. doi:10.1212/wnl.14.9.815. PMID 14215595. S2CID 43526449.
- Sodee DB (December 1968). "Comparison of 99mTc-pertechnetate and 197Hg-chlormerodrin for brain scanning". Journal of Nuclear Medicine. 9 (12): 645. PMID 5729215.
- FDA, Approved Drug Products with Therapeutic Equivalence Evaluations, US Department Of Health And Human Service, 1989.
Diuretics (C03) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Sulfonamides (and etacrynic acid) |
| ||||||||
Potassium-sparing (at CD) |
| ||||||||
Osmotic diuretics (PT, DL) | |||||||||
Vasopressin receptor inhibitors (DCT and CD) | |||||||||
Other | |||||||||
Combination products | |||||||||
|
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |